Winner Medical Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000047Z8
CNY
32.86
0.41 (1.26%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
2,600.87
2,690.90
2,605.31
2,907.81
2,036.54
2,124.49
1,909.02
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,600.87
2,690.90
2,605.31
2,907.81
2,036.54
2,124.49
1,909.02
Raw Material Cost
1,344.89
1,510.12
1,459.39
1,698.98
1,196.78
1,175.40
1,106.68
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
22.16
16.67
15.54
17.20
13.64
12.76
11.26
Selling and Distribution Expenses
841.80
790.34
690.64
774.11
565.57
637.20
533.07
Other Expenses
7.46
7.98
7.08
9.41
6.97
4.92
5.95
Total Expenditure (Excl Depreciation)
2,283.46
2,396.97
2,236.37
2,584.37
1,845.70
1,874.54
1,710.55
Operating Profit (PBDIT) excl Other Income
317.4
293.9
368.9
323.40000000000003
190.79999999999998
249.89999999999998
198.5
Other Income
59.53
57.65
41.59
130.69
59.37
85.59
56.12
Operating Profit (PBDIT)
345.08
498.23
523.66
501.00
399.46
427.23
370.79
Interest
22.16
16.67
15.54
17.20
13.64
12.76
11.26
Exceptional Items
-14.87
5.87
2.18
-90.62
-4.84
-6.85
14.43
Gross Profit (PBDT)
1,255.98
1,180.78
1,145.92
1,208.84
839.75
949.09
802.34
Depreciation
0.00
169.63
169.63
167.78
167.78
150.27
150.27
Profit Before Tax
308.05
317.79
340.67
225.40
213.21
257.35
223.70
Tax
48.32
54.91
72.53
71.25
29.24
36.90
30.25
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
239.90
243.43
248.57
142.41
168.82
201.73
182.42
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
239.90
243.43
248.57
142.41
168.82
201.73
182.42
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
16.74
13.01
13.18
12.10
11.15
10.99
11.09
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
256.64
256.44
261.75
154.51
179.96
212.72
193.51
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
11,490.18
11,523.01
11,411.85
11,151.28
11,363.03
11,431.21
11,572.72
Earnings per share (EPS)
0.41
0.42
0.43
0.24
0.29
0.35
0.31
Diluted Earnings per share
0.41
0.42
0.43
0.24
0.29
0.35
0.31
Operating Profit Margin (Excl OI)
10.98%
10.07%
11.99%
6.97%
8.46%
9.01%
8.61%
Gross Profit Margin
11.84%
18.11%
19.59%
13.52%
18.71%
19.19%
19.59%
PAT Margin
9.22%
9.05%
9.54%
4.9%
8.29%
9.5%
9.56%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2025 is -3.34% vs 3.29% in Jun 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2025 is 0.08% vs -2.03% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is -35.18% vs -8.61% in Jun 2025

stock-summary

Interest

QoQ Growth in quarter ended Sep 2025 is 32.93% vs 7.74% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

Compare Quarterly Results Of Winner Medical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
2,600.87
0
2,600.87
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,600.87
0
2,600.87
Raw Material Cost
1,344.89
0
1,344.89
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
22.16
0
22.16
Selling and Distribution Expenses
841.80
0
841.80
Other Expenses
7.46
0.00
7.46
Total Expenditure (Excl Depreciation)
2,283.46
0
2,283.46
Operating Profit (PBDIT) excl Other Income
317.41
0.00
317.41
Other Income
59.53
0
59.53
Operating Profit (PBDIT)
345.08
0
345.08
Interest
22.16
0
22.16
Exceptional Items
-14.87
0
-14.87
Gross Profit (PBDT)
1,255.98
0
1,255.98
Depreciation
0.00
0
0.00
Profit Before Tax
308.05
0
308.05
Tax
48.32
0
48.32
Provisions and contingencies
0
0
0.00
Profit After Tax
239.90
0
239.90
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
239.90
0
239.90
Share in Profit of Associates
0
0
0.00
Minority Interest
16.74
0
16.74
Other related items
0.00
0.00
0.00
Consolidated Net Profit
256.64
0
256.64
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
11,490.18
0
11,490.18
Earnings per share (EPS)
0.41
0
0.41
Diluted Earnings per share
0.41
0
0.41
Operating Profit Margin (Excl OI)
10.98%
0%
0.00
10.98%
Gross Profit Margin
11.84%
0%
0.00
11.84%
PAT Margin
9.22%
0%
0.00
9.22%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 260.09 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -3.34% vs 3.29% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 27.71% vs 16.80% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 25.66 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 0.08% vs -2.03% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 42.56% vs -87.84% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 28.56 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -35.18% vs -8.61% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -16.02% vs 57.02% in Sep 2024

Quarterly - Interest
Interest 2.22 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 32.93% vs 7.74% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 63.24% vs -12.26% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 10.98%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024